New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...

(Reuters Health) - - In men with localized prostate cancer discovered because they had symptoms or noticed during a work-up for another medical problem, radical prostate surgery leads to an average of ...

– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...

PROCEPT BioRobotics recently reported two major milestones in its WATER IV prostate cancer program, completing enrollment in the randomized WATER IV RP trial comparing Aquablation therapy with radical ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

OhhMed Medical Ltd., a pioneering medical technology firm specialising in male urology, today announced the initiation of a ...

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

Wider resection of localized high-risk prostate cancer at surgery may come at the cost of sexual function and urinary incontinence. A phase 2 trial tested the merits of neoadjuvant therapy.

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...

For many men navigating the challenging journey of prostate cancer, radical prostatectomy represents a life-saving sur ...

Up to 72% of patients with prostate cancer who undergo radical prostatectomy experience urinary incontinence in the first 3 months after surgery. Up to 72% of patients experience urinary incontinence ...